Novo Nordisk investe US$ 600 milhões em parceria com Metaphore Biotechnologies para inovação em tratamentos de obesidade

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Novo Nordisk investe US$ 600 milhões em parceria com Metaphore Biotechnologies para inovação em tratamentos de obesidade

/jornal/2024/05/novo-nordisk-investe-us-600-milhoes-em-parceria-com-metaphore-biotechnologies-para-inovacao-em-tratamentos-de-obesidade/

Novo Nordisk (BOV:N1VO34)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Novo Nordisk Charts.

Novo Nordisk (BOV:N1VO34)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Novo Nordisk Charts.

News

More News Articles

Global Developments (PK)

Intergrated Cannabis Sol... (PK)

1812 Brewing (PK)

SMC Entertainment (PK)

Impact Fusion (PK)

Clean Vision (QB)

Bell Buckle (PK)

AMC Entertainment

Branded Legacy (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions